Thus, AR inactivation by androgen deprivation or antiandrogen treatment, which leads to telomere dysfunction and telomere aberrations that include telomere breakage and sister chromatid telomere fusion, may contribute to castration resistant growth of prostate cancer cells through a mechanism involving telomere instability and subsequent genome instability. Here, AR is linked to prostate carcinoma.